Skip to content
DraconiticResearch
Search Sources API
220,472 studies31 sourcesUpdated 35 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,770 studies

  1. CAMOR and specific oncogene-driven lncRNAs mediate carcinogenic functions downstream of MYC, mutant KRAS, and mutant TP53
    M. Grzes, A. Jaiswar, W. Kazmierczak +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. Myeloid Lectin Profiling Identifies SYK as a Targetable Signaling Node for Remodeling Immunosuppressive Tumor-Associated Macrophages in Breast Cancer
    G. Trindade, G. Domenici, M. Pinto +6
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. Effects of Polyunsaturated Fatty Acids and Selenoneine on Growth and Lipidomic Profiles in Patient-Derived Prostate Cancer Organoids
    M. S. Sylla, C. Jobin, L. Berthiaume +10
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. A case report on the pathogenesis of BAP1 inactivating melanocytomas (BIMTs).
    Alexander Michael Diaz, Lawrence Adam Schiffman, Evan Miller +1
    JAAD case reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. Inequalities and practice-level predictors of cancer diagnostic activity: longitudinal study in England
    A. M. Fatimah, S. W. Merriel, E. Whitfield +3
    medRxivPreprintCC BYFull textOncologymedRxiv
  6. A spatial single-cell transcriptomic atlas of metastatic breast cancer progression
    Z. Dauyey, A. Velds, R. Gobits +17
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  7. Sex-associated miR-4286 is related to Breslow thickness and TILs in stage II/III primary cutaneous melanoma
    A. Z. Reynolds, D. L. Corcoran, L. Luo +10
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  8. A mitoxyperilysis-derived spatial signature predicts immune exclusion and survival in oral squamous cell carcinoma
    J. Liu, D. Zhang, Z. Meng +1
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  9. A cyclooxygenase-2 associated pro-tumorigenic inflammatory signature predicts outcome after surgery in lung cancer
    V. Fife, C. P. Bromley, M. Roberts +24
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  10. Oncogene Driver Status Modulates TP53 Prognostic Impact in Advanced NSCLC
    M. Pan, C. Jiang, J. Song +14
    medRxivPreprintPublic domainFull textOncologymedRxiv
  11. Longitudinal Economic Burden for Non–Muscle-Invasive Bladder Cancer by EAU Progression Risk Groups Using the Prospective Multicenter COBLAnCE Cohort Linked to the French National Healthcare System Database
    Aldéric M Fraslin, Simone Benhamou, Thierry Lebret +20
    European Urology Open SciencePeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  12. ctDNA-based detection of residual disease: implications for management of non-metastatic NSCLC
    Charline Leclercq, Mylène Wespiser, Gaëlle Tachon +3
    Frontiers in OncologyPeer-reviewedCC BYFull textOncologyHAL
  13. Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling
    Déborah Suissa, Marine Fidelle, Ella Reich +48
    Nature MedicinePeer-reviewedCC BY-NC-SA 4.0Full text5 citedOncologyHAL
  14. Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma
    Esther Hazane Leroyer, Caroline Ziegler, Charline Moulin +5
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full text7 citedOncologyHAL
  15. Photochemical Carbamate Scission Redefines Metal-Based PhotoCORMs through Multi-Output Activation
    Rakesh Halder, Shamik Chanda, Manisha Rathore +14
    ChemRxivPreprintCC BYFull textOncologyChemRxiv
  16. Rational Design of a Red-Light Absorbing dinuclear Ruthenium (II) Complex with Photodynamic potential
    Julia D. Magdaleno, Giorgia Chinigò, Francesca Bianco +6
    ChemRxivPreprintCC BYFull textOncologyChemRxiv
  17. Identification of a G-quadruplex-forming cell-free DNA fragment as a biomarker for the precise diagnosis of hepatocellular carcinoma
    Jianzhe Sun, Xucong Teng, Weizhi Zhang +3
    Chemical SciencePeer-reviewedCC BY-NC 3.0Full textOncologyPMC
  18. Hypofractionated Total Marrow and Lymphoid Irradiation for Relapsed/Refractory Leukemia Using Helical Tomotherapy: Workflow and Dosimetric Analysis
    Wenjie Ni, Xiunan Wang, Hui Yang +5
    Yonsei Medical JournalPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  19. Transcriptome profiling of cell-free RNAs in prostate cancer patients on active surveillance
    J. G. Foster, E. Wozniak, C. A. Mein +4
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  20. eIF4A inhibition disrupts resistance-associated translational and metabolic programs in BRAF-mutant melanoma
    A. Schcolnik-Cabrera, M. Takdenti, A. Sadr Hashemi Nejad +12
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  21. The RNA cargo of plasma-derived extracellular vesicles in mCRPC patients captures cancer cells and tumor microenvironment signals
    F. Vannuccini, Y. Ciani, V. Mugoni +21
    bioRxivPreprintCC BYFull textOncologybioRxiv
  22. DLL3 expression predicts response and long-term outcome in small cell lung cancer patients treated with tarlatamab
    B. Zhang, L. Hong, K. Wang +20
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  23. Single genome analysis of normal cells identifies the early steps of kidney cancer.
    J. P. Margaria, G. B. Pipitone, A. Larcher +16
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  24. Pannexin 1 inhibition reduces tumorigenic properties of patient-derived glioblastoma cells through the HIPPO and Wnt signalling pathways
    D. Johnston, M. Huver, R. Kanji +12
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  25. A mammary-specific microfluidic device for studying post-radiotherapy vascular-immune cell interactions
    S. E. Martello, S. N. Luna, K. Derr +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv